Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-05
2006-09-05
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S188000, C514S277000, C514S352000, C514S354000, C514S356000, C546S304000, C546S315000, C546S345000
Reexamination Certificate
active
07101868
ABSTRACT:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
REFERENCES:
patent: 3226394 (1965-12-01), Schipper et al.
patent: 5532358 (1996-07-01), Kelly
patent: 6140351 (2000-10-01), Arnaiz et al.
patent: 19830430 (2000-01-01), None
patent: 0 947 500 (1999-10-01), None
patent: 1 219 609 (2002-07-01), None
patent: 2 168 227 (1973-08-01), None
patent: 2000 256358 (2000-09-01), None
patent: WO 96/41795 (1996-12-01), None
patent: WO 98/24771 (1998-06-01), None
patent: WO 98/45268 (1998-10-01), None
patent: WO 99/32477 (1999-07-01), None
patent: WO 99/62885 (1999-12-01), None
patent: WO 00/02851 (2000-01-01), None
patent: 2000002851 (2000-01-01), None
patent: WO 00/27819 (2000-05-01), None
patent: WO 00/27820 (2000-05-01), None
patent: WO 00/39111 (2000-07-01), None
patent: WO 00/39117 (2000-07-01), None
patent: WO 01/29009 (2001-04-01), None
patent: WO 01/30745 (2001-05-01), None
patent: WO 01/55114 (2001-08-01), None
patent: WO 01/55115 (2001-08-01), None
patent: WO 01/81311 (2001-11-01), None
patent: WO 01/85671 (2001-11-01), None
patent: WO 01/85691 (2001-11-01), None
patent: WO 01/85715 (2001-11-01), None
patent: WO 02/055501 (2002-07-01), None
patent: WO 02/66470 (2002-08-01), None
patent: WO 02/064546 (2002-08-01), None
patent: WO 02/68406 (2002-09-01), None
patent: WO 03/024935 (2003-03-01), None
Zhmurenko et al, Fiziologicheski Aktivnye Veshchestva, 8,89-92(1976), also cited as Chemical Abstract DN 86:171214.
Konshin et al., “Synthesis and antimicrobial activity of arylamides of N-(4-pyridyl)anthranilic acid”, Chen. Abstr. 97:109837 (1981).
Breier et al., “The role of vascular endothelial growth factor in blood vessel formation”, Trends in Cell Biology 6:454-456 (1996).
Connell et al., “Patent focus on cancer chemotherapeutics. II Angiogenesis agents: Apr. 2000-Sep. 2000”, Exp. Opin. Ther. Patents 11:77-114 (2001).
Chemical Abstract DN 132:93104, also cited as WO 00/02851.
Heinisch et al., “Pyridazines, 89'. on the Synthesis of Novel 1,2-Diazine Containing Tricyclic Systems: Preparation of Dipyridazinodiazepinones”, Heterocycles 51(5):1035-1050 (1999).
Singh, et al., “Substituted Imidazolines and Their CNS Activity” Ind.J.Het.Chem. 2: 129-132 (1992).
Seto, et al., “Molecular Self-Assembly through Hydrogen Bonding: Supramolecular Aggregates Based on the Cyanuric Acid-Melamine Lattice” J.Am.Chem.Soc. 115: 905-916 (1993).
Bennett & Plum, editors., Cecil Textbook of Medicine, W.B. Saunders Co., 1004-1010 (1996).
Uckun et al., “Current Cancer Drug Targets”, Structure Based Design of Novel Anti-Cancer Agents, 1:59-71 (2001).
Zhmurenko et al., “Fiziologicheski Aktivnye Veshchestva”, 8:89-92 (1976), also cited as Chem. Abstact DN 86:171214.
Askew, Jr. Benny C.
Booker Shon
Cai Guolin
Chen Guoqing
Croghan Michael
Amgen Inc.
Bulock Joseph W.
Patel Sudhaker B.
Raymond Richard L.
LandOfFree
Substituted arylamine derivatives and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted arylamine derivatives and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted arylamine derivatives and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3544170